You’ve hit your search limit
Start your free trial to keep exploring full traffic and performance insights.
Get Started- Home
- Analyses d’applications gratuites
- IV Medications Gahart
Analyse de l'application IV Medications Gahart pour le 18 mai
IV Medications Gahart
- Unbound Medicine, Inc.
- App Store Apple
- Gratuit
- Médical
Trusted for over 45 years, Intravenous Medications contains everything needed for the safe and effective administration of IV drugs. Updated annually, this comprehensive resource contains detailed monographs that include dosage, administration, contraindications, precautions, interactions, antidotes, and more. This app helps nurses, nursing students, and health professionals avoid errors by using the built-in calculator to determine precise dilution and rate of administration. Download this app to see how it will build confidence and help you provide better patient care with its intuitive, quick-access format.
Features of Intravenous Medications include:
• 400+ detailed generic and trade name IV drug monographs
• Annual updates
• New monographs featuring recently FDA approved drugs
• Helpful calculator and charts for dilution and rate of administration
• Black Box Warnings highlighting critical information
• Blue-screened text call attention to important circumstances that may not warrant Black Box Warnings.
• Life-stage dosage variances for geriatric, pediatric, infant, and neonatal patients
• Updated drug interactions, precautions, alerts, and patient teaching instructions for all IV drugs
• Dilution and dosage charts within monographs provide quick access to essential clinical information
• Advanced Search help you find terms fast
• “Favorites” for bookmarking important entries
• Personalize your app with notes and highlights
FREE 14-DAY TRIAL: WHAT TO EXPECT
• First-time users can access Unbound's complete IV Medications mobile app free for 14 days
• After 14 days, your iTunes account will be charged $49.99 for a one-year subscription unless you have turned off auto-renew at least 24 hours before the free trial ends.
• To manage your subscriptions, open Apple's “Settings” app and tap on the “iTunes & App Store" entry. Tap your Apple ID at the top of the screen and login. Tap subscriptions, then tap the subscription you wish to manage.
• NOTE: If you choose not to purchase a subscription, content will no longer be viewable after the free trial period.
iTunes automatic renewal feature: Your subscription automatically renews unless auto-renew is turned off 24 hours prior to the conclusion of your current 12 month period. Your iTunes account will automatically be charged the current renewal rate ($49.99) within 24 hours prior to the end of the subscription period. This will ensure you receive all updates and continued web access for the following year. If you choose not to renew, you will be able to use the app, however will not receive updates.
Authors: Shelly Rainforth Collins, PharmD, BCGP
Publisher: Elsevier
Powered by: Unbound Medicine
Unbound Privacy Policy: www.unboundmedicine.com/privacy
Unbound Terms of Use: https://www.unboundmedicine.com/end_user_license_agreement
Classement dans le store
Le classement des stores est basé sur plusieurs paramètres définis par Google et Apple.
Toutes les catégories dans
États-Unis--
Médical dans
États-Unis--
Créez un compte pour voir les téléchargements mensuels moyensContactez-nous
Statistiques de classement dans le temps pour IV Medications Gahart
Classement d'utilisation et classement Apple App Store de Similarweb pour IV Medications Gahart
Classement
Aucune donnée disponible
Ranking par pays pour IV Medications Gahart
Pays dans lesquels IV Medications Gahart est le mieux classé dans ses principales catégories
Aucune donnée à afficher
Principaux concurrents & apps alternatives
Applications ayant une forte probabilité d'être utilisées par les mêmes utilisateurs, à partir du même store.
IV Medications Elsevier
Skyscape Medpresso Inc
Handbook on Injectable Drugs
Skyscape Medpresso Inc
PEPID®
PEPID, LLC
Dosage Calculations Made Easy
Skyscape Medpresso Inc
mai 18, 2026